Beximco Pharma eyes herbal medicine market with new subsidiary
Bangladesh, Nov. 16 -- Beximco Pharmaceuticals is expanding its footprint into the herbal medicine market to capitalise on growing demand by setting up a wholly owned subsidiary.
Advertisement
The move aligns with the drug maker's aim to diversify its product portfolio and tap new growth opportunities in the healthcare sector.
The proposed subsidiary, Beximco Pharma Nutraceuticals, will have an initial paid-up capital of Tk 100 million, fully subscribed by Beximco Pharmaceuticals, against an authorised capital of Tk 1 billion.
The board approved the incorporation of the subsidiary at a meeting on November 12, according to a disclosure posted on the Dhaka Stock Exchange (DSE) on Sunday.
Demand for herbal medicine is growing, as many p...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.